The value of glucocorticoid co-therapy in different rheumatic diseases - positive and adverse effects

Adrenal insufficiency

(2014) Evangelia Charmandari et al.   LANCET

Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis

(2013) Marije F. Bakker   ANNALS OF INTERNAL MEDICINE

EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases

(2013) N Duru et al.   ANNALS OF THE RHEUMATIC DISEASES

Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case–control analysis

(2012) William G Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Development and validation of a risk score for serious infection in patients with rheumatoid arthritis

(2012) Cynthia S. Crowson et al.   ARTHRITIS AND RHEUMATISM

The use of glucocorticoids in Systemic Lupus Erythematosus. After 60years still more an art than science

(2012) Remco K.M.A.C. Luijten et al.   AUTOIMMUNITY REVIEWS

FRAX updates 2012

(2012) Eugene McCloskey et al.   CURRENT OPINION IN RHEUMATOLOGY

Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?

(2012) M. C. van der Goes et al.   OSTEOPOROSIS INTERNATIONAL

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

(2012) Jasvinder A. Singh et al.   ARTHRITIS CARE & RESEARCH

Decline of Mean Initial Prednisone Dosage From 10.3 to 3.6 mg/day to Treat Rheumatoid Arthritis Between 1980 and 2004 in One Clinical Setting, With Long-Term Effectiveness of Dosages Less Than 5 mg/day

(2012) Theodore Pincus et al.   ARTHRITIS CARE & RESEARCH

Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis

(2012) Jessica Widdifield et al.   ARTHRITIS CARE & RESEARCH

The influence of systemic glucocorticoid therapy upon the risk of non-serious infection in older patients with rheumatoid arthritis: a nested case-control study

(2011) W. G. Dixon et al.   ANNALS OF THE RHEUMATIC DISEASES

Glucose tolerance, insulin sensitivity and  -cell function in patients with rheumatoid arthritis treated with or without low-to-medium dose glucocorticoids

(2011) J. N. Hoes et al.   ANNALS OF THE RHEUMATIC DISEASES

Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: Balance between diabetogenic effects and inflammation reduction

(2011) Debby den Uyl et al.   ARTHRITIS AND RHEUMATISM

Depth and volume of resorption induced by osteoclasts generated in the presence of RANKL, TNF-alpha/IL-1 or LIGHT

(2011) Guillaume Mabilleau et al.   CYTOKINE

Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection

(2011) Erika Bélard et al.   INFLAMMATORY BOWEL DISEASES

Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years

(2011) L. Fardet et al.   RHEUMATOLOGY

EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

(2010) S. van Assen et al.   ANNALS OF THE RHEUMATIC DISEASES

Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis

(2010) S. L. Gorter et al.   ANNALS OF THE RHEUMATIC DISEASES

Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice

(2010) M. C. van der Goes et al.   ANNALS OF THE RHEUMATIC DISEASES

Insulin resistance in early untreated rheumatoid arthritis patients

(2010) Dina Shahin et al.   CLINICAL BIOCHEMISTRY

The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights

(2010) Agnes E. Coutinho et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis

(2010) Jos N. Hoes et al.   Nature Reviews Rheumatology

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

(2010) Jennifer M. Grossman et al.   ARTHRITIS CARE & RESEARCH

Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases

(2009) M. C. van der Goes et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

(2009) M J L Peters et al.   ANNALS OF THE RHEUMATIC DISEASES

Treatment of Polymyalgia Rheumatica

(2009) José Hernández-Rodríguez   ARCHIVES OF INTERNAL MEDICINE

Rheumatoid Arthritis

(2009) Ivy A. Ku et al.   CIRCULATION JOURNAL

EULAR recommendations for the management of Behcet disease

(2008) G Hatemi et al.   ANNALS OF THE RHEUMATIC DISEASES

Dose-related patterns of glucocorticoid-induced side effects

(2008) D Huscher et al.   ANNALS OF THE RHEUMATIC DISEASES

Remission achieved after 2 years treatment with low-dose prednisolone in addition to disease-modifying anti-rheumatic drugs in early rheumatoid arthritis is associated with reduced joint destruction still present after 4 years: an open 2-year continuation study

(2008) I Hafstrom et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of large vessel vasculitis

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

EULAR recommendations for the management of primary small and medium vessel vasculitis

(2008) C Mukhtyar et al.   ANNALS OF THE RHEUMATIC DISEASES

Inflammation‐associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms

(2008) Cecilia P. Chung et al.   ARTHRITIS AND RHEUMATISM

Adipose tissue dysfunction in obesity, diabetes, and vascular diseases

(2008) G. R. Hajer et al.   EUROPEAN HEART JOURNAL

Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial

(2008) Frank Buttgereit et al.   LANCET

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

(2008) Hein JEM Janssens et al.   LANCET

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Disease activity and disability but probably not glucocorticoid treatment predicts loss in bone mineral density in women with early rheumatoid arthritis

(2008) C. Book et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY